» Articles » PMID: 35936216

Rutin and Quercetin Counter Doxorubicin-Induced Liver Toxicity in Wistar Rats Their Modulatory Effects on Inflammation, Oxidative Stress, Apoptosis, and Nrf2

Overview
Publisher Wiley
Date 2022 Aug 8
PMID 35936216
Authors
Affiliations
Soon will be listed here.
Abstract

The presented study was performed to verify whether rutin and/or quercetin can inhibit liver injury induced by doxorubicin (DXR) in male Wistar rats. In this study, male Wistar rats were treated via the oral route with rutin and quercetin (50 mg/kg) either alone or in combination every other day for five weeks concomitant with receiving intraperitoneal DXR (2 mg/kg) two times a week for five successive weeks. Quercetin, rutin, and their combination significantly improved the deteriorated serum AST, ALT, and ALP activities and total bilirubin level, as well as albumin, AFP, and CA 19.9 levels in DXR-injected rats. Treatments of the DXR-injected group with quercetin and rutin prevented the elevation in liver lipid peroxidation and the reduction in superoxide dismutase, glutathione-S-transferase and glutathione peroxidase activities, and glutathione content. Treatments with quercetin and rutin significantly repressed the elevated expression of liver p53 and TNF- and enhanced Nrf2 expression. Furthermore, the treatments significantly reduced DXR-induced liver histological changes. In conclusion, rutin and quercetin either alone or in combination may have potential preventive effects against DXR-induced hepatotoxicity through inhibiting oxidative stress, inflammation, and apoptosis as well as modulating the Nrf2 expression.

Citing Articles

A meta-analysis of risk factors for cardiovascular adverse events with anthracycline based chemotherapy in lymphoma patients.

Dai B, Xu J, Wang B BMC Cancer. 2025; 25(1):162.

PMID: 39875837 PMC: 11773729. DOI: 10.1186/s12885-024-13305-3.


Avenanthramide-C ameliorate doxorubicin-induced hepatotoxicity via modulating Akt/GSK-3β and Wnt-4/β-Catenin pathways in male rats.

Alwaili M, Abu-Almakarem A, Aljohani S, Alkhodair S, Al-Bazi M, Eid T Front Mol Biosci. 2024; 11:1507786.

PMID: 39687571 PMC: 11646862. DOI: 10.3389/fmolb.2024.1507786.


Glutathione and Selenium Supplementation Attenuates Liver Injury in Diethylnitrosamine-Induced Hepatocarcinogenic Mice by Enhancing Glutathione-Related Antioxidant Capacities.

Hsiao Y, Huang S, Cheng S, Hsu C, Huang Y Int J Mol Sci. 2024; 25(21).

PMID: 39518894 PMC: 11546938. DOI: 10.3390/ijms252111339.


Qualitative Phytochemical Analysis and Assessments of Analgesic and Antidiarrheal Activity of the Methanolic Leaf Extract of Cheilanthes tenuifolia: In Vivo Study.

Rakib A, Chowdhury R, Bhuia M, Al Hasan M, Sheikh S, Ansari S Immun Inflamm Dis. 2024; 12(11):e70055.

PMID: 39508723 PMC: 11542299. DOI: 10.1002/iid3.70055.


Quercetin prevents rats from type 1 diabetic liver damage by inhibiting TGF-ꞵ/apelin gene expression.

Firouzeh G, Susan A, Zeinab K Curr Res Pharmacol Drug Discov. 2024; 7:100201.

PMID: 39351284 PMC: 11440311. DOI: 10.1016/j.crphar.2024.100201.


References
1.
Llesuy S, Arnaiz S . Hepatotoxicity of mitoxantrone and doxorubicin. Toxicology. 1990; 63(2):187-98. DOI: 10.1016/0300-483x(90)90042-f. View

2.
Othman A, Amer M, El-Missiry M . Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats. J Appl Toxicol. 2001; 21(6):469-73. DOI: 10.1002/jat.782. View

3.
QuanJun Y, GenJin Y, LiLi W, YongLong H, Yan H, Jie L . Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study. PLoS One. 2017; 12(1):e0169567. PMC: 5224977. DOI: 10.1371/journal.pone.0169567. View

4.
Injac R, Perse M, Obermajer N, Djordjevic-Milic V, Prijatelj M, Djordjevic A . Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas. Biomaterials. 2008; 29(24-25):3451-60. DOI: 10.1016/j.biomaterials.2008.04.048. View

5.
Ma Q . Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013; 53:401-26. PMC: 4680839. DOI: 10.1146/annurev-pharmtox-011112-140320. View